Hong Kong-listed Shanghai Pharma will acquire Cardinal Health's Chinese distribution business for $557 millionhttp://on.wsj.com/2AHxFp7
1 reply
15 retweets
18 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.